Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik’s revolutionary technology. SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ — Gravitas Medical Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA)…
Gravitas Medical Inc. Announces SECOND FDA Breakthrough Device Designation for its Entarik System; Pediatric Patients to Benefit from Enteral Nutrition Innovation!
This post was originally published on this site